FDA Inspection
James P. Lin, M.D., Inc.James P. Lin, M.D., Inc. – FDA Inspection, Mar 5, 2020
Record Details
This FDA Inspection record concerns James P. Lin, M.D., Inc., with an inspection on March 5, 2020, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- James P. Lin, M.D., Inc.
- Inspection Date
- March 5, 2020
- Product Type
- Biologics
View Company Profile
ID · a2ea2f03-54aa-4b55-80a5-4d20da634552
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1120143
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
Other FDA inspections of James P. Lin, M.D., Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| August 22, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for James P. Lin, M.D., Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.